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We recently introduced a new kind of bead-based surface coverage immunoassay, based on 
the specific interaction between surface-bound “small” magnetic beads (1 µm in diameter)  
and a flow of “large” magnetic beads (3 µm in diameter), the latter ones carrying antigens 
(Ags) and being simultaneously used as detection labels. [1] While this immunoassay 
technique allows attaining extremely low limits of detection, down to the attomolar 
concentration range, the origin of this noteworthy performance remained unclear up to now. 
Furthermore, dose-response curves obtained with this assay, as well as with similar bead-
based techniques, show a peculiar non-linear dependence on Ag concentration, which was 
so far unexplained.  
 
In this work we introduce a comprehensive theoretical model finally allowing complete 
understanding of these unsolved issues. Our model is based on the concept of “magnetic 
bead-scanning”: in our assay, large magnetic beads, each one carrying down to single Ags, 
while transported by hydrodynamic forces, are subjected to sequential stochastic 
reorientations induced by magnetic dipolar interactions with substrate-bound small magnetic 
beads (Figure 1). We identify the “magnetic bead-scanning” as the main assay feature 
distinguishing our work from previously reported bead-based surface coverage assays. [2, 3] 
To describe and predict this phenomenon, our model encompasses a “random walk-based” 
description of the bead capture, in which the displacement of the contact point between an 
Ag-carrying large bead and the small magnetic bead pattern is modeled by stochastic moves 
over the surface of the moving particle, until this point coincides with the position of an Ag, 
thus resulting in the bead specific capture.  
 
Our model elucidates the extremely low limit of detection attained with this kind of assay by 
carefully considering the probability of single immunocomplex formation, which is 
dramatically enhanced by the bead-scanning mechanism (Figure 2). The random walk-based 
modeling approach allows then explaining the exact behavior of the assay dose-response 
curves, for different ligand-receptor systems and over a wide range of Ag concentrations 
(Figure 3). Because of the pioneering nature of our model in explaining the principle of ultra-
low sensitivity detection, we believe that the proposed model will represent a powerful tool for 
the design of novel magnetic bead-based immunoassays with unprecedented performance 
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Figure 2. (a) In case of no bead‐scanning, large magnetic beads slide over the substrate and probe it at one 
point, providing only a single chance for ligand‐receptor binding. This is due to the pinning of the beads’ 
magnetic moment imposed by the external magnetic field. Bead‐scanning instead occurs when large beads 
move in presence of a magnetic field and the small bead array. In this case, the contact point describes a line 
on the surface of the large particle, increasing the chance for ligand‐receptor encounter. Moreover, a different 
section of the large bead surface is explored at each interaction with a small bead group. (b) Probability of 
specific capture of single large beads (Pcapture), as a function of the radii of the large and small beads.  
 
Figure 3. Experimental results of detection of (a) biotinylated anti‐streptavidin and (b) TNF‐α, spiked as Ag in 5 
µL fetal bovine serum (FBS), as obtained from [1] and fitted according to our model predictions.  The “random‐
walk” modeling approach explains the particular behavior of these experimental dose‐response curves, for 
both ligand‐receptor systems and over the whole range of analyzed concentrations. 
Figure 1. (a) Schematic 
representation of the principle of 
our magnetic bead‐based assay. (b) 
Specific immunocomplex formation 
at the interface between a large and 
a small bead is responsible for the 
capture of large beads on the array. 
(c) Counting of the number of 
captured large particles provides the 
measure of the Ag‐concentration in 
the sample under test. 
